Bioventus set for five-day winning streak, says completes divestiture
** Shares of medical device co Bioventus Inc BVS.O up ~9%
at $2.28 - set for a five-day winning streak
** Co says it has completed the divestiture of its Wound
business, which makes products used for treating wounds, to
LifeNet Health
** BVS shares have more than doubled since it announced the
sale of the Wound business earlier this month for a total cash
consideration of $85 million
** Bioventus stock is down ~13% this year
(Reporting by Raghav Mahobe)
((Raghav.Mahobe@thomsonreuters.com;))
Recent news on Bioventus
See all newsBioventus Inc. reports results for the quarter ended June 30 - Earnings Summary
Bioventus Q2 revenue misses estimates on surgical solutions decline
Bioventus Inc expected to post earnings of 22 cents a share - Earnings Preview
Bioventus Q1 revenue rises 7%, beats expectations
U.S. STOCKS ON THE MOVE -Erasca Inc, Regenxbio, Natgas stocks